| Year |
Citation |
Score |
| 2023 |
Kaszuba CM, Rodems BJ, Sharma S, Franco EI, Ashton JM, Calvi LM, Bajaj J. Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Journal of Visualized Experiments : Jove. PMID 38009736 DOI: 10.3791/66093 |
0.528 |
|
| 2023 |
Quarato ER, Salama NA, Li AJ, Smith CO, Zhang J, Kawano Y, McArthur M, Liesveld JL, Becker MW, Elliott MR, Eliseev RA, Calvi LM. Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling. Cell Death & Disease. 14: 428. PMID 37452070 DOI: 10.1038/s41419-023-05931-9 |
0.489 |
|
| 2023 |
Kfoury YS, Ji F, Jain E, Mazzola MC, Schiroli G, Papazian A, Mercier FE, Sykes DB, Kiem A, Randolph MA, Abdel-Wahab OI, Calvi LM, Sadreyev R, Scadden DT. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression. Blood Advances. PMID 37450380 DOI: 10.1182/bloodadvances.2022008268 |
0.486 |
|
| 2023 |
Kawano H, Kawano Y, Yu C, LaMere MW, McArthur MJ, Becker MW, Ballinger SW, Gojo S, Eliseev RA, Calvi LM. Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells. Cells. 12. PMID 37296594 DOI: 10.3390/cells12111473 |
0.309 |
|
| 2023 |
Kawano Y, Kawano H, Ghoneim D, Fountaine TJ, Byun DK, LaMere MW, Mendler JH, Ho T, Salama NA, Myers JR, Hussein SE, Frisch BJ, Ashton JM, Azadniv M, Liesveld JL, ... ... Calvi LM, et al. Myelodysplastic syndromes disable human CD271 VCAM1 CD146 niches supporting normal hematopoietic stem/progenitor cells. Biorxiv : the Preprint Server For Biology. PMID 37066307 DOI: 10.1101/2023.04.09.536176 |
0.732 |
|
| 2023 |
Zhang H, Liesveld JL, Calvi LM, Lipe BC, Xing L, Becker MW, Schwarz EM, Yeh SA. The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies. Bone Research. 11: 15. PMID 36918531 DOI: 10.1038/s41413-023-00249-w |
0.503 |
|
| 2022 |
Lynch OF, Calvi LM. Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review. Cells. 11. PMID 35159389 DOI: 10.3390/cells11030580 |
0.392 |
|
| 2021 |
Seyfried AN, McCabe A, Smith JNP, Calvi LM, MacNamara KC. CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia. Leukemia. PMID 33744909 DOI: 10.1038/s41375-021-01219-z |
0.412 |
|
| 2021 |
Calvi LM. FGF-23: a novel actor in stem cell mobilization. Blood. 137: 1434-1436. PMID 33734341 DOI: 10.1182/blood.2020010538 |
0.32 |
|
| 2021 |
Ackun-Farmmer MA, Soto CA, Lesch ML, Byun D, Yang L, Calvi LM, Benoit DSW, Frisch BJ. Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21402. PMID 33724567 DOI: 10.1096/fj.202000938RR |
0.714 |
|
| 2020 |
Calvi LM. Improved in vivo Experimental Screening Identifies an Anabolic Analog of 1,25 Dihydroxyvitamin D3 With Minimal Bone Resorption Activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31905250 DOI: 10.1002/Jbmr.3933 |
0.412 |
|
| 2019 |
Calvi LM, Li AJ, Becker MW. What is the role of the microenvironment in MDS? Best Practice & Research. Clinical Haematology. 32: 101113. PMID 31779976 DOI: 10.1016/J.Beha.2019.101113 |
0.407 |
|
| 2019 |
Azadniv M, Myers JR, McMurray HR, Guo N, Rock P, Coppage ML, Ashton J, Becker MW, Calvi LM, Liesveld JL. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia. PMID 31492897 DOI: 10.1038/S41375-019-0568-8 |
0.593 |
|
| 2019 |
Calvi LM, Frisch BJ, Kingsley PD, Koniski A, Love TM, Williams JP, Palis J. Acute and late effects of combined internal and external radiation exposures on the hematopoietic system. International Journal of Radiation Biology. 1-49. PMID 31329495 DOI: 10.1080/09553002.2019.1644932 |
0.666 |
|
| 2019 |
Calvi LM, Hofbauer LC. A Novel Strategy for Repairing Multiple Myeloma Bone Lesions: Lessons From Murine Models. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31071234 DOI: 10.1002/Jbmr.3723 |
0.414 |
|
| 2019 |
Banerjee T, Calvi LM, Becker MW, Liesveld JL. Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes. Blood Reviews. PMID 31036385 DOI: 10.1016/J.Blre.2019.04.004 |
0.399 |
|
| 2019 |
Frisch BJ, Hoffman CM, Latchney SE, LaMere MW, Myers J, Ashton J, Li AJ, Saunders J, Palis J, Perkins AS, McCabe A, Smith JN, McGrath KE, Rivera-Escalera F, McDavid A, ... ... Calvi LM, et al. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. Jci Insight. 5. PMID 30998506 DOI: 10.1172/Jci.Insight.124213 |
0.764 |
|
| 2019 |
Kawano Y, Byun DK, Frisch BJ, Kawano H, LaMere MW, Johnston CJ, Williams JP, Calvi LM. Local Irradiation Induces Systemic Inflammatory Response and Alteration of the Hematopoietic Stem Cell Niche Blood. 134: 1213-1213. DOI: 10.1182/Blood-2019-131809 |
0.771 |
|
| 2019 |
Fountaine TJ, LaMere MW, Byun DK, Myers JR, Ashton JM, Liesveld JL, Kfoury Y, Scadden DT, Becker MW, Calvi LM. A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic Syndrome (MDS) in Primary Human Bone Marrow Aspirates Blood. 134: 1708-1708. DOI: 10.1182/Blood-2019-130227 |
0.448 |
|
| 2018 |
Ayoub E, Wilson MP, McGrath KE, Li AJ, Frisch BJ, Palis J, Calvi LM, Zhang Y, Perkins AS. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nature Communications. 9: 4239. PMID 30315161 DOI: 10.1038/S41467-018-06208-Y |
0.675 |
|
| 2018 |
Staversky RJ, Byun DK, Georger MA, Zaffuto BJ, Goodman A, Becker MW, Calvi LM, Frisch BJ. The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers. Scientific Reports. 8: 14691. PMID 30279500 DOI: 10.1038/S41598-018-32978-Y |
0.774 |
|
| 2018 |
Hoffman CM, Han J, Calvi LM. Impact of aging on bone, marrow and their interactions. Bone. PMID 30010082 DOI: 10.1016/J.Bone.2018.07.012 |
0.468 |
|
| 2018 |
Chiu YG, Lillis J, Singh R, Liesveld JL, Calvi LM, Ashton JM, Aljitawi OS. Role of RasGRP3 in EPO/EPOR Signaling and Transmigration of Human Hematopoietic CD34+ Cells Blood. 132: 4531-4531. DOI: 10.1182/Blood-2018-99-116807 |
0.436 |
|
| 2018 |
Kfoury Y, Jain E, Myers JR, Ji F, Sykes DB, Mercier F, Papazian A, Le C, Randolph MA, Steensma DP, Abdel-Wahab OI, Calvi LM, Sadreyev RI, Becker MW, Scadden DT. Specific Bone Marrow Mesenchymal Subsets in Patients with Myelodysplastic Syndromes Harbor Molecular Perturbations That Alter the Dynamics of Competition between Pre-Leukemic Clones and Normal Cells Blood. 132: 938-938. DOI: 10.1182/Blood-2018-99-115242 |
0.443 |
|
| 2018 |
Palis J, McGrath K, Frisch B, Li A, Ayoub E, Zhang YS, Becker M, Perkins A, Calvi L, Steiner L. Modeling Defective Erythropoiesis in Myelodysplastic Syndrome (MDS) Experimental Hematology. 64: S91-S92. DOI: 10.1016/J.Exphem.2018.06.114 |
0.617 |
|
| 2018 |
Kousteni S, Frisch BJ, Galan‐Diez M, Calvi LM. The Hematopoietic Niche and Bone Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 966-973. DOI: 10.1002/9781119266594.Ch125 |
0.768 |
|
| 2017 |
Li AJ, Calvi LM. The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression. Experimental Hematology. PMID 28826860 DOI: 10.1016/J.Exphem.2017.08.003 |
0.447 |
|
| 2017 |
Lawal RA, Zhou X, Batey K, Hoffman CM, Georger MA, Radtke F, Hilton MJ, Xing L, Frisch BJ, Calvi LM. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28277610 DOI: 10.1002/Jbmr.3106 |
0.799 |
|
| 2017 |
Oleksyn D, Zhao J, Vosoughi A, Zhao JC, Misra R, Pentland AP, Ryan D, Anolik J, Ritchlin C, Looney J, Anandarajah AP, Schwartz G, Calvi LM, Georger M, Mohan C, et al. PKK deficiency in B cells prevents lupus development in Sle lupus mice. Immunology Letters. PMID 28274793 DOI: 10.1016/J.Imlet.2017.03.002 |
0.402 |
|
| 2017 |
Latchney SE, Calvi LM. The aging hematopoietic stem cell niche: Phenotypic and functional changes and mechanisms that contribute to hematopoietic aging. Seminars in Hematology. 54: 25-32. PMID 28088984 DOI: 10.1053/J.Seminhematol.2016.10.001 |
0.428 |
|
| 2017 |
Perkins AS, Wilson M, Ayoub E, Zhang Y, Kathleen ME, Palis J, Li AJ, Calvi LM. High-Level EVI1 Perturbs Hematopoietic Function By Skewing Cells Towards Myeloid Phenotype Via Induction of PU.1/ Spi1 Â Transcription Blood. 130: 2505-2505. DOI: 10.1182/Blood.V130.Suppl_1.2505.2505 |
0.402 |
|
| 2016 |
Azadniv M, Myers JR, McMurray H, Ashton JM, Guo N, Rock P, Coppage M, Calvi LM, Becker MW, Liesveld JL. Bone Marrow Mesenchymal Stem Cells from Acute Myelogenous Leukemia Patients Demonstrate Adipogenic Differentiation Propensity Blood. 128: 5064-5064. DOI: 10.1182/Blood.V128.22.5064.5064 |
0.541 |
|
| 2016 |
Staversky RJ, Yang L, Goodman AN, Georger MA, Becker MW, Calvi LM, Frisch BJ. CCL3 Regulates Normal Hematopoiesis but Is Not Essential for the Maintenance of a Long-Term Engrafting Hematopoietic Stem Cell Blood. 128: 1482-1482. DOI: 10.1182/Blood.V128.22.1482.1482 |
0.807 |
|
| 2015 |
Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, Georger MA, Evans AG, Liesveld JL, Becker MW, Calvi LM. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood. PMID 26637787 DOI: 10.1182/Blood-2015-06-653113 |
0.79 |
|
| 2015 |
Calvi LM, Link DC. The hematopoietic stem cell niche in homeostasis and disease. Blood. 126: 2443-51. PMID 26468230 DOI: 10.1182/Blood-2015-07-533588 |
0.562 |
|
| 2015 |
Sivagnanalingam U, Balys M, Eberhardt A, Wang N, Myers JR, Ashton JM, Becker MW, Calvi LM, Mendler JH. Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia. Plos One. 10: e0132375. PMID 26177509 DOI: 10.1371/Journal.Pone.0132375 |
0.427 |
|
| 2015 |
Evans AG, Calvi LM. Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis. Annals of the New York Academy of Sciences. 1335: 63-77. PMID 25351294 DOI: 10.1111/Nyas.12562 |
0.579 |
|
| 2015 |
Mendler JH, Balys M, Sivagnanalingam U, Eberhardt A, Thorne K, Ho T, LaMere MW, Moore S, McMurray H, Myers JR, Ashton JM, O'Dwyer K, Liesveld JL, Calvi LM, Becker MW. Distinct Properties of Leukemia Stem Cells in Primary Refractory Acute Myeloid Leukemia Blood. 126: 685-685. DOI: 10.1182/Blood.V126.23.685.685 |
0.419 |
|
| 2015 |
Ho T, Jordan CT, LaMere MW, Ashton JM, O'Dwyer K, Mendler JH, Liesveld JL, Wang ES, Guzman ML, Calvi LM, Becker MW. A Role for IL1RAP in Acute Myelogenous Leukemia Stem Cells Following Treatment and Progression Blood. 126: 4266-4266. DOI: 10.1182/Blood.V126.23.4266.4266 |
0.45 |
|
| 2015 |
Niswander LM, Koniski AD, Seraichick A, Catherman SC, Fegan KH, Kingsley PD, Calvi LM, Palis J. Prostaglandin E2 Promotes the Sequential Recovery of Bone Marrow Vasculature and the Megakaryocyte Lineage Following Radiation Injury Blood. 126: 3597-3597. DOI: 10.1182/Blood.V126.23.3597.3597 |
0.525 |
|
| 2015 |
Li AJ, Balderman SR, Frisch BJ, LaMere MW, Becker MW, Calvi LM. Restoration of the Bone Marrow Microenvironment Improves Hematopoietic Function in a Murine Model of Myelodysplastic Syndrome Blood. 126: 358-358. DOI: 10.1182/Blood.V126.23.358.358 |
0.795 |
|
| 2015 |
Frisch BJ, Goodman AN, Staversky RJ, Bromberg O, Tu X, Bellido TM, Calvi LM. Osteocyte-Mediated Parathyroid Hormone (PTH) Signaling Regulates Hematopoietic Stem Cells Under Physiologic and Continuous PTH Exposure Blood. 126: 1199-1199. DOI: 10.1182/Blood.V126.23.1199.1199 |
0.769 |
|
| 2014 |
Balderman SR, Calvi LM. Biology of BM failure syndromes: role of microenvironment and niches. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2014: 71-6. PMID 25696837 DOI: 10.1182/Asheducation-2014.1.71 |
0.387 |
|
| 2014 |
Frisch BJ, Calvi LM. Osteoblasts as leukemia-initiating cells. Bonekey Reports. 3: 572. PMID 25228985 DOI: 10.1038/Bonekey.2014.67 |
0.809 |
|
| 2014 |
Hoffman CM, Calvi LM. Minireview: complexity of hematopoietic stem cell regulation in the bone marrow microenvironment. Molecular Endocrinology (Baltimore, Md.). 28: 1592-601. PMID 25083740 DOI: 10.1210/Me.2014-1079 |
0.543 |
|
| 2014 |
Frisch BJ, Calvi LM. Hematopoietic stem cell cultures and assays. Methods in Molecular Biology (Clifton, N.J.). 1130: 315-24. PMID 24482184 DOI: 10.1007/978-1-62703-989-5_24 |
0.744 |
|
| 2014 |
Calvi LM, Link DC. Cellular complexity of the bone marrow hematopoietic stem cell niche. Calcified Tissue International. 94: 112-24. PMID 24101231 DOI: 10.1007/S00223-013-9805-8 |
0.595 |
|
| 2014 |
Smith JNP, Hoffman CM, Goodman AN, Calvi LM. Osteoblastic VEGF Coordinates Remodeling of the Hematopoietic Stem Cell Niche Blood. 124: 772-772. DOI: 10.1182/Blood.V124.21.772.772 |
0.649 |
|
| 2014 |
Balderman SR, Frisch BJ, LaMere MW, Goodman AN, Becker MW, Calvi LM. Microenvironmental Contribution to Dysfunctional Hematopoiesis in a Murine Model of Myelodysplastic Syndrome Blood. 124: 4359-4359. DOI: 10.1182/Blood.V124.21.4359.4359 |
0.768 |
|
| 2014 |
Akwaa F, Rubinova R, Frisch BJ, LaMere MW, O'Dwyer KM, Liesveld JL, Becker MW, Calvi LM. Modulation of Interaction of Human Osteoprogenitor Cells with Hematopoietic Stem and Progenitor Cells Blood. 124: 2933-2933. DOI: 10.1182/Blood.V124.21.2933.2933 |
0.803 |
|
| 2014 |
Williams J, Hernady E, Koniski A, Kingsley P, Finkelstein J, Palis J, Calvi L. EP-1812: Combined internal/external radiation exposure induces late functional injury in bone marrow stem cell compartment Radiotherapy and Oncology. 111: S293-S294. DOI: 10.1016/S0167-8140(15)31930-7 |
0.428 |
|
| 2013 |
Calvi LM. Osteolineage cells and regulation of the hematopoietic stem cell. Best Practice & Research. Clinical Haematology. 26: 249-52. PMID 24309526 DOI: 10.1016/J.Beha.2013.10.004 |
0.5 |
|
| 2013 |
Li JY, Adams J, Calvi LM, Lane TF, Weitzmann MN, Pacifici R. Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B. Blood. 122: 2346-57. PMID 23954891 DOI: 10.1182/Blood-2013-03-487801 |
0.512 |
|
| 2013 |
Smith JN, Calvi LM. Concise review: Current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells (Dayton, Ohio). 31: 1044-50. PMID 23509002 DOI: 10.1002/Stem.1370 |
0.554 |
|
| 2013 |
Steinman RA, De Castro IO, Shrayyef M, Chengazi V, Giampoli E, Van Der Sloot P, Calvi LM, Wittlin SD, Hammes SR, Hou R. Two cases of malignant struma ovarii with metastasis to pelvic bone. Gynecologic and Obstetric Investigation. 75: 139-44. PMID 23391779 DOI: 10.1159/000345863 |
0.396 |
|
| 2013 |
Porter RL, Georger MA, Bromberg O, McGrath KE, Frisch BJ, Becker MW, Calvi LM. Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells (Dayton, Ohio). 31: 372-83. PMID 23169593 DOI: 10.1002/Stem.1286 |
0.837 |
|
| 2013 |
Dhillon RS, Xie C, Tyler W, Calvi LM, Awad HA, Zuscik MJ, O'Keefe RJ, Schwarz EM. PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 586-97. PMID 22991274 DOI: 10.1002/Jbmr.1765 |
0.469 |
|
| 2013 |
Lawal RA, McGrath KE, Calvi LM. Erythroid Lineage Cells Are Found In Close Association With Bone In The Marrow Microenvironment Blood. 122: 945-945. DOI: 10.1182/Blood.V122.21.945.945 |
0.474 |
|
| 2013 |
Balderman SR, Frisch BJ, LaMere MW, Goodman AN, Becker MW, Calvi LM. Disruption Of The Hematopoietic Stem and Progenitor Cell Pool and Bone Marrow Microenvironment In a Murine Model Of Myelodysplastic Syndrome Blood. 122: 2756-2756. DOI: 10.1182/Blood.V122.21.2756.2756 |
0.758 |
|
| 2012 |
Li JY, Adams J, Calvi LM, Lane TF, DiPaolo R, Weitzmann MN, Pacifici R. PTH expands short-term murine hemopoietic stem cells through T cells. Blood. 120: 4352-62. PMID 22955916 DOI: 10.1182/Blood-2012-06-438531 |
0.477 |
|
| 2012 |
Loiselle AE, Frisch BJ, Wolenski M, Jacobson JA, Calvi LM, Schwarz EM, Awad HA, O'Keefe RJ. Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury. Plos One. 7: e40602. PMID 22792383 DOI: 10.1371/Journal.Pone.0040602 |
0.711 |
|
| 2012 |
Bromberg O, Frisch BJ, Weber JM, Porter RL, Civitelli R, Calvi LM. Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood. 120: 303-13. PMID 22596259 DOI: 10.1182/Blood-2011-09-377853 |
0.836 |
|
| 2012 |
Calvi LM, Bromberg O, Rhee Y, Weber JM, Smith JN, Basil MJ, Frisch BJ, Bellido T. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood. 119: 2489-99. PMID 22262765 DOI: 10.1182/Blood-2011-06-360933 |
0.844 |
|
| 2012 |
Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 119: 540-50. PMID 21957195 DOI: 10.1182/Blood-2011-04-348151 |
0.806 |
|
| 2012 |
Frisch BJ, Shafiq I, Porter RL, Weber JM, Smith JN, Bromberg O, Basil M, Dhillon RS, Schwarz EM, Calvi LM. Intermittent in Vivo Parathyroid Hormone (PTH) Treatment Results in Jagged 1 (Jag 1) Dependent and Independent Effects On Hematopoietic Stem Cells (HSCs) Blood. 120: 642-642. DOI: 10.1182/Blood.V120.21.642.642 |
0.835 |
|
| 2011 |
Smith JN, Calvi LM. Regulatory Interactions in the Bone Marrow Microenvironment. Ibms Bonekey. 8: 96-111. PMID 26213605 DOI: 10.1138/20110495 |
0.613 |
|
| 2011 |
Calvi LM. Agrin complicates the niche. Blood. 118: 2641-2. PMID 21903897 DOI: 10.1182/Blood-2011-06-361253 |
0.378 |
|
| 2011 |
Lawal RA, Calvi LM. The niche as a target for hematopoietic manipulation and regeneration. Tissue Engineering. Part B, Reviews. 17: 415-22. PMID 21902610 DOI: 10.1089/Ten.Teb.2011.0197 |
0.541 |
|
| 2011 |
Smith JN, Weber JM, Calvi LM. PTH Stimulates Osteoblastic VEGF-A Production and Remodels Bone Marrow Micro-Endothelial Structures Blood. 118: 722-722. DOI: 10.1182/Blood.V118.21.722.722 |
0.709 |
|
| 2011 |
Porter RL, Georger MA, Calvi LM. Prostaglandin E2 Inhibits Apoptosis in Hematopoietic Stem and Progenitor Cells and Enhances Their Survival Following Sub-Lethal Radiation Injury, Blood. 118: 3401-3401. DOI: 10.1182/Blood.V118.21.3401.3401 |
0.811 |
|
| 2010 |
Weber JM, Calvi LM. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone. 46: 281-5. PMID 19679213 DOI: 10.1016/J.Bone.2009.08.007 |
0.749 |
|
| 2010 |
Porter RL, Calvi LM. Prostaglandin E2 Is Rapidly Produced In Response to Bone Marrow Injury and Improves Survival of Primitive Hematopoietic Cells Blood. 116: 407-407. DOI: 10.1182/Blood.V116.21.407.407 |
0.816 |
|
| 2010 |
Frisch BJ, Ashton JM, Jordan CT, Calvi LM. Microenvironmental Changes In An In Vivo Model of Myeloid Leukemia Negatively Regulate Osteoblastic Cells. Blood. 116: 1219-1219. DOI: 10.1182/Blood.V116.21.1219.1219 |
0.81 |
|
| 2009 |
Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood. 114: 4054-63. PMID 19726721 DOI: 10.1182/Blood-2009-03-205823 |
0.858 |
|
| 2009 |
Porter RL, Calvi LM. Key endothelial signals required for hematopoietic recovery. Cell Stem Cell. 4: 187-8. PMID 19265650 DOI: 10.1016/J.Stem.2009.02.005 |
0.777 |
|
| 2009 |
Weber JM, Frisch BJ, Porter RL, Bromberg O, Olm-shipman AJ, Awad H, Calvi LM. In Vivo Parathyroid Hormone Treatment Expands All Multipotent Primitive Hematopoietic Cell Subsets. Blood. 114: 1449-1449. DOI: 10.1182/Blood.V114.22.1449.1449 |
0.849 |
|
| 2008 |
Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body JJ, Boyce BF, Calvi LM, Hadji P, McCloskey EV, Saad F, Smith MR, Suva LJ, Taichman RS, Vessella RL, et al. Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6387-95. PMID 18927277 DOI: 10.1158/1078-0432.Ccr-08-1572 |
0.506 |
|
| 2008 |
Frisch BJ, Porter RL, Calvi LM. Hematopoietic niche and bone meet. Current Opinion in Supportive and Palliative Care. 2: 211-7. PMID 18685423 DOI: 10.1097/Spc.0B013E32830D5C12 |
0.834 |
|
| 2008 |
Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Calvi LM, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM. Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis and Rheumatism. 58: 2019-29. PMID 18576355 DOI: 10.1002/Art.23546 |
0.372 |
|
| 2008 |
Porter RL, Calvi LM. Communications between bone cells and hematopoietic stem cells. Archives of Biochemistry and Biophysics. 473: 193-200. PMID 18410740 DOI: 10.1016/J.Abb.2008.04.001 |
0.815 |
|
| 2008 |
Porter RL, Frisch BJ, O’Keefe RJ, Calvi LM. Prostaglandin E2 (PGE2) Treatment Rapidly Increases the Fraction of Non-Dividing Hematopoietic Stem Cells (HSCs) Blood. 112: 73-73. DOI: 10.1182/Blood.V112.11.73.73 |
0.854 |
|
| 2008 |
Frisch B, Ashton JM, Olm-shipman A, Xing L, Jordan CT, Calvi L. Reciprocal Synergistic Interactions of Leukemic Cells with Osteoclast Progenitors in the Bone Microenvironment Blood. 112: 322-322. DOI: 10.1182/Blood.V112.11.322.322 |
0.812 |
|
| 2008 |
Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT. Erratum: Corrigendum: Therapeutic targeting of a stem cell niche Nature Biotechnology. 26: 241-241. DOI: 10.1038/Nbt0208-241C |
0.423 |
|
| 2007 |
Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT. Therapeutic targeting of a stem cell niche. Nature Biotechnology. 25: 238-43. PMID 17237769 DOI: 10.1038/Nbt1281 |
0.502 |
|
| 2007 |
Frisch BJ, Weber JM, Porter RL, Gigliotti BJ, Smith JN, Olm-Shipman AJ, O’Keefe RJ, Jordan CT, Calvi LM. In Vivo Treatment with Prostaglandin E2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells. Blood. 110: 1254-1254. DOI: 10.1182/Blood.V110.11.1254.1254 |
0.838 |
|
| 2007 |
Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT. Erratum: Corrigendum: Therapeutic targeting of a stem cell niche Nature Biotechnology. 25: 944-944. DOI: 10.1038/nbt0807-944b |
0.31 |
|
| 2006 |
Calvi LM. Osteoblastic activation in the hematopoietic stem cell niche. Annals of the New York Academy of Sciences. 1068: 477-88. PMID 16831945 DOI: 10.1196/Annals.1346.021 |
0.623 |
|
| 2006 |
Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner LA, Guzman ML, Calvi LM. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone. 39: 485-93. PMID 16647886 DOI: 10.1016/J.Bone.2006.03.002 |
0.799 |
|
| 2006 |
Calvi LM, Frisch BJ, Gigliotti BJ, Christianson CA, Weber JM, Jordan CT, O’Keefe RJ. Prostaglandin E2 (PGE2) Regulates Osteoblastic Jagged1 and Expands Primitive Hematopoietic Cells In Vivo. Blood. 108: 89-89. DOI: 10.1182/Blood.V108.11.89.89 |
0.841 |
|
| 2006 |
Calvi LM. Hematopoietic-osteoblastic interactions in the hematopoietic stem cell niche Bonekey-Osteovision. 3: 10-18. DOI: 10.1138/20060210 |
0.486 |
|
| 2005 |
Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grünewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR, Scadden DT. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. The Journal of Experimental Medicine. 201: 1781-91. PMID 15928197 DOI: 10.1084/Jem.20041992 |
0.541 |
|
| 2005 |
Forsythe SR, Weber JM, Christianson CA, Gigliotti BJ, Frisch BJ, Calvi LM. Osteoblastic Cells (OBs) and the Hematopoietic Microenvironment: Parathyroid Hormone (PTH) Increases the Notch Ligand Jagged1 (J1) in a Specific Subpopulation of OBs. Blood. 106: 1396-1396. DOI: 10.1182/Blood.V106.11.1396.1396 |
0.829 |
|
| 2004 |
Kuznetsov SA, Riminucci M, Ziran N, Tsutsui TW, Corsi A, Calvi L, Kronenberg HM, Schipani E, Robey PG, Bianco P. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. The Journal of Cell Biology. 167: 1113-22. PMID 15611335 DOI: 10.1083/Jcb.200408079 |
0.647 |
|
| 2004 |
Calvi LM, Shin HI, Knight MC, Weber JM, Young MF, Giovannetti A, Schipani E. Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation. Mechanisms of Development. 121: 397-408. PMID 15110049 DOI: 10.1016/J.Mod.2004.02.004 |
0.645 |
|
| 2004 |
Calvi LM, Weber JM, Guzman ML, Christianson CA, Milner LM, Jordan CT. Osteoblastic Cells and the Hematopoietic Microenvironment: The Notch ligand Jagged1 Is Increased in Osteoblastic Stromal Cells by Parathyroid Hormone (PTH)Treatment. Blood. 104: 1284-1284. DOI: 10.1182/Blood.V104.11.1284.1284 |
0.732 |
|
| 2003 |
Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 425: 841-6. PMID 14574413 DOI: 10.1038/Nature02040 |
0.752 |
|
| 2003 |
Chiusaroli R, Maier A, Knight MC, Byrne M, Calvi LM, Baron R, Krane SM, Schipani E. Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments. Endocrinology. 144: 4106-16. PMID 12933685 DOI: 10.1210/En.2003-0254 |
0.548 |
|
| 2001 |
Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. The Journal of Clinical Investigation. 107: 277-86. PMID 11160151 DOI: 10.1172/Jci11296 |
0.579 |
|
| 2001 |
Calvi LM, Schipani E. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia. Journal of Endocrinological Investigation. 23: 545-54. PMID 11021773 DOI: 10.1007/Bf03343773 |
0.37 |
|
| Show low-probability matches. |